+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Nail Diseases Drug"

From
Nail Diseases - Epidemiology Forecast to 2032 - Product Thumbnail Image

Nail Diseases - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
  • 2 Results (Page 1 of 1)
Loading Indicator

The Nail Diseases Drug market is a subset of the Dermatological Drugs market, which includes medications used to treat skin conditions. Nail Diseases Drugs are used to treat a variety of nail-related conditions, such as fungal infections, psoriasis, and onychomycosis. These drugs are typically administered orally or topically, depending on the severity of the condition. Common active ingredients in Nail Diseases Drugs include terbinafine, itraconazole, and ciclopirox. Nail Diseases Drugs are available both over-the-counter and by prescription. Over-the-counter medications are typically used to treat milder cases of nail-related conditions, while prescription medications are used to treat more severe cases. In addition, some Nail Diseases Drugs are available in combination with other medications, such as antibiotics, to treat more complex cases. Some companies in the Nail Diseases Drug market include Pfizer, Novartis, Merck, and Johnson & Johnson. Show Less Read more